
Targeted Drug, Chemo Similar for Older STS Patients
- Wellness
- Admin COUPONS
- September 30, 2020
(MedPage Today) — Older patients with advanced or metastatic soft-tissue sarcoma (STS) had similar progression-free survival (PFS) whether they initially received standard chemotherapy or the angiogenesis inhibitor pazopanib (Votrient), which…
%%item_READ_MORE…_button%%